Glutathione (GSH) is an important member of cellular antioxidative system. In cancer cells, a
high level of GSH is indispensable to scavenge excessive reactive oxygen species (ROS) …

Glutathione (GSH), the main redox buffer, has long been recognized as a pivotal modulator
of tumor initiation, progression and metastasis. It is also implicated in the resistance of …

Clinical applications of nanozyme‐initiated chemodynamic therapy (NCDT) have been
severely limited by the poor catalytic efficiency of nanozymes, insufficient endogenous …

Cancer cells frequently exhibit resistance to various molecular and nanoscale drugs, which
inevitably affects the drugs' therapeutic outcomes. Overexpression of glutathione (GSH) has …

In view of certain unique internalization features of the tumor microenvironment
(TME)(mainly including hypoxia, acidity and higher concentrations of H 2 O 2 and GSH) …

Photodynamic therapy (PDT), an emergent noninvasive cancer treatment, is largely
dependent on the presence of efficient photosensitizers (PSs) and a sufficient oxygen …

Metal–organic frameworks (MOFs) have been at the forefront of nanotechnological research
for the past decade owing to their high porosity, high surface area, diverse configurations …

The therapeutic effect of chemodynamic therapy (CDT) is significantly restricted by the stern
reaction conditions and slow reaction rate of the Fenton reaction (pH 3–4). Herein, we report …

Nanozymes have shown great promise in reactive oxygen species (ROS)-mediated tumor
therapy with mitigated side effects but are normally limited by the complex tumor …

The combination of photothermal treatment and chemodynamic therapy has attracted
extensive attention for improving therapeutic effects and compensating the insufficiency of …